Hericium erinaceus – ein Pilz mit großem Potenzial

Zusammenfassung

Hericium erinaceus ist ein essbarer Pilz, der in der traditionellen chinesischen Medizin (TCM) seit Jahrhunderten wegen seiner gesundheitsfördernden Eigenschaften geschätzt und v. a. bei Problemen im Magen-Darm-Trakt angewendet wird. Der Pilz enthält ein breites Spektrum an bioaktiven Verbindungen, u. a. Erinacine und Hericenone. Für sie wurden antiinflammatorische, antioxidative, antibakterielle, immunstimulierende, neuroprotektive und neurotrophe Aktivitäten nachgewiesen. In diesem Artikel werden In-vitro- und präklinische Untersuchungen zusammengefasst und aktuelle klinische Studien vergleichend vorgestellt. Die Studienergebnisse unterstreichen das Potenzial der Pilze für eine mögliche präventive bzw. therapeutische Anwendung insbesondere bei neurologischen Problemen.

Abstract

Hericium erinaceus is an edible mushroom that has been valued in traditional Chinese medicine (TCM) for centuries for its health-promoting properties and is mainly used to treat gastrointestinal disorders. The mushroom contains a broad spectrum of bioactive compounds, including erinacines and hericenones. The compounds have been shown to have anti-inflammatory, antioxidative, antibacterial, immunostimulating, neuroprotective and neurotrophic activities. This article summarizes in vitro and preclinical studies and presents actual clinical studies. The study results underline the potential of the mushrooms for a possible preventive or therapeutic application, particularly in the case of neurological problems.

Schlüsselwörter

Hericium erinaceus - Igelstachelbart - klinische Studien - kognitive Fähigkeiten - Depression - Alzheimer-Krankheit

Keywords

Hericium erinaceus - Lion’s Mane - clinical studies - cognitive functions - depression - Alzheimer’s disease

• Literatur

• 1 Ehlers S, Schnitzler WH. Submerskultur von Hericium erinaceus . J Appl Bot 1998; 72: 168-173
• 2 Gonkhom D, Luangharn T, Raghoonundon B. et al. Hericium: A review of the cultivation, health-enhancing applications, economic importance, industrial, and pharmaceutical applications. Fungal Biotec 2021; 1: 117-129
• 3 Guthmann J. Heilende Pilze weltweit: Beschreibung – Inhaltsstoffe – Wirkung. 3. Aufl. Wiebelsheim: Quelle & Meyer; 2024
• 4 Lelley JI. Die Heilkraft der Pilze. Goch: B.O.S.S Druck und Medien; 2008. 155.
• 5 Wang K, Bao L, Qi Q. et al. Erinacines C-L, isoindolin-1-ones with alpha-glukosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus . J Nat Proc 2015; 78: 146-154
• 6 Ryu SH, Hong SM, Khan Z. et al. Neurotrophic isoindolinones from the fruiting bodies of Hericium erinaceus . Bioorg Med Chem Lett 2021; 31: 127714
• 7 Kolotushkina EV, Moldavan MG, Voronin KY, Skibo GG. The influence of Hericium erinaceus extract on myelination process in vitro. Fiziol Zh 2003; 49: 38-45
• 8 Li H, See HJ, Moon BK. et al. Neuritogenic activity of hot water extract from Hericium erinaceus. J Mushroom Sci. Prod 2013; 11: 117-123
• 9 Han SR, Jun JA, Yang HS, Oh TJ. Comparison of physiological activity of solvent extracts from Hericium erinaceus . Ind J Sci Technol 2015; 8: 1-7
• 10 Noh HJ, Yang HH, Kim GS. et al. Chemical constituents of Hericium erinaceum associated with the inhibitory activity against cellular senescence in human umbilical vascular endothelial cells. J Enzyme Inhib Med Chem 2015; 30: 934-940
• 11 Shen T, Morlock G, Zorn H. Production of cyathane type secondary metabolites by submerged cultures of Hericium erinaceus and evaluation of their antibacterial activity by direct bioautography. Fungal Biol Biotechnol 2015; 2: 8
• 12 Jiang S, Wang Y, Zhang X. Comparative studies on extracts from Hericium erinaceus by different polarity reagents to gain higher antioxidant activities. Exp Ther Med 2016; 12: 513-517
• 13 Li W, Lee SH, Jang HD. et al. Antioxidant and anti-osteoporotic activities of aromatic compounds and sterols from Hericium erinaceum . Molecules 2017; 22: 108
• 14 Cheng JH, Tsai CL, Lien YY. et al. High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity. BMC Complement Alternat Med 2016; 16: 170
• 15 Wu D, Yang S, Tang C. et al. Structural properties and macrophage activation of cell wall polysaccharides from the fruiting bodies of Hericium erinaceus . Polymers 2018; 10: 850
• 16 Kushairi N, Phan CW, Sabaratnam V. et al. Lion’s Mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. suppresses H₂O₂-induced oxidative damage and LPS-induced inflammation in HT22 Hippocampal neurons and BV2 microglia. Antioxidants 2019; 8: 261
• 17 Huang HAT, Ho CH, Sung HY. et al. Hericium erinaceus mycelium and its small bioactive compounds promote oligodendrocyte maturation with an increase in myelin basic protein. Sci Rep 2021; 11: 6551
• 18 Samberkar S, Gandhi S, Naidu M. et al. Lion’s Mane, Hericium erinaceus and tiger milk, Lignosus rhinocerotis (higher Basidiomycetes) medicinal mushrooms stimulate neurite outgrowth in dissociated cells of brain, spinal cord, and retina: an in vitro study. Int J Med Mushrooms 2015; 17: 1047-1054
• 19 Wang M, Zhang Y, Xiao X. et al. A polysaccharide isolated from mycelia of the Lion’s Mane medicinal mushroom Hericium erinaceus (Agaricomycetes) induced apoptosis in precancerous human gastric cells. Int J Med Mushrooms 2017; 19: 1053-1060
• 20 Li W, Zhou W, Kim EJ. et al. Isolation and identification of aromatic compounds in Lion’s Mane mushroom and their anticancer activities. Food Chem 2015; 170: 336-342
• 21 Wong KH, Naidu M, David P. et al. Peripheral nerve regeneration following crush injury to rat peroneal nerve by aqueous extract of medicinal mushroom Hericium erinaceus (Bull.: Fr) Pers. (Aphyllophoromycetideae). Evid Based Complement Alternat Med 2011; 2011: 580752
• 22 Trovato A, Siracusa R, Di Paola R. et al. Redox modulation of cellular stress response and lipoxin A4 expression by Hericium erinaceus in rat brain: relevance to Alzheimer’s disease pathogenesis. Immun Ageing 2016; 13: 23
• 23 Tsai-Teng T, Chin-Chu C, Li-Ya L. et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice. J Biomed Sci 2016; 23: 49
• 24 Zhang J, An S, Hu W. et al. The neuroprotective properties of Hericium erinaceus in glutamate-damaged differentiated pc12 cells and an Alzheimer’s disease mouse model. Int J Mol Sci 2016; 17: 1810
• 25 Furuta S, Kuwahara R, Hiraki E. et al. Hericium erinaceus extracts alter behavioral rhythm in mice. Biomed Res 2016; 37: 227-232
• 26 Bui VT, Wu KW, Chen CC. et al. Exploring the synergistic effects of erinacines on microglial regulation and Alzheimer’s pathology under metabolic stress. CNS Neurosci Ther 2024; 30: e70137
• 27 Shirvani M, Nouri F, Sahiri A. et al. Neuroprotective effects of dehydroepiandrosterone and Hericium erinaceus in scopolamine-induced Alzheimer’s diseases-like symptoms in male rats. Cell Biochem Biophys 2024; 82: 2853-2864
• 28 Mori K, Obara Y, Moriya T, Inatomi S, Nakahata N. Effects of Hericium erinaceus on amyloid β (25-35) peptide-induced learning and memory deficits in mice. Biomed Res 2011; 32: 67-72
• 29 Rossi P, Cesaroni V, Brandalise F. et al. Dietary supplementation of Lion’s Mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), and spatial memory in wild-type mice. Int J Med Mushrooms 2018; 20: 485-494
• 30 Chiu CH, Chyau CC, Chen CC. et al. Erinacine A-enriched Hericium erinaceus mycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice. Int J Mol Sci 2018; 19: 341
• 31 Aramsirirujiwet Y, Leepasert T, Piamariya D, Thong-asa W. Benefits of erinacines from different cultivate formulas on cognitive deficits and anxiety-like behaviour in mice with trimethyltin-induced toxicity. Tropl Life Sci Res 2023; 34: 165-183
• 32 Martínez-Mármol R, Chai Y, Conroy JN. et al. Hericerin derivatives activates a pan-neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory. J Neurochemistry 2023; 165: 791-808
• 33 Brandalise F, Cesaroni V, Gregori A. et al. Dietary supplementation of Hericium erinaceus increases mossy fiber-CA3 hippocampal neurotransmission and recognition memory in wild-type mice. Evid Based Complement Alternat Med 2017; 2017: 3864340
• 34 Chaiyasut C, Sivamaruthi BS. Anti-hyperglycemic property of Hericium erinaceus – A mini review. Asian Pac J Trop Biomed 2017; 7: 1036-1040
• 35 Liang B, Guo Z, Xie F, Zhao A. Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats. BMC Complement Alternat Med 2013; 13: 253
• 36 Zhang C, Li J, Hu C. et al. Antihyperglycaemic and organic protective effects on pancreas, liver and kidney by polysaccharides from Hericium erinaceus SG-02 in streptozotocin-induced diabetic mice. Sci Rep 2017; 7: 10847
• 37 Hiwatashi K, Kosaka Y, Suzuki N. et al. Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet. Biosci Biotechnol Biochem 2010; 74: 1447-1451
• 38 Qin M, Geng Y, Lu Z. et al. Anti-inflammatory effects of ethanol extract of Lion’s Mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), in mice with ulcerative colitis. Int J Med Mushrooms 2016; 18: 227-234
• 39 Ren Y, Geng Y, Du Y. et al. Polysaccharide of Hericium erinaceus attenuates colitis in C57BL/6 mice via regulation of oxidative stress, inflammation-related signaling pathways and modulating the composition of the gut microbiota. J Nutr Biochem 2018; 57: 67-76
• 40 Wong JY, Abdulla MA, Raman J. et al. Gastroprotective effects of Lion’s Mane mushroom Hericium erinaceus (Bull.:Fr.) Pers. (Aphyllophoromycetideae) extract against ethanol-induced ulcer in rats. Evid Based Complement Alternat Med 2013; 2013: 492976
• 41 Diling C, Xin Y, Chaoqun Z. et al. Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota. Oncotarget 2017; 8: 85838-85857
• 42 Blagodatski A, Yatsunskaya M, Mikhailova V. et al. Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy. Oncotarget 2018; 9: 29259-29274
• 43 Xie XQ, Geng Y, Guan O. et al. Influence of short-term consumption of Hericium erinaceus on serum biochemical markers and the changes of the gut microbiota: a pilot study. Nutrients 2021; 13: 1008
• 44 Muhanna M, Lund I, Bromberg M. et al. Case Report: ALSUntangled #73: Lion’s Mane. Amyotroph Lateral Scler Frontotemporal Degener 2024; 25: 420-423
• 45 Chong PS, Fung ML, Wong KH, Lim LW. Therapeutic potential of Hericium erinaceus for depressive disorder. Int J Mol Sci 2020; 21: 163
• 46 Mori K, Inatomi S, Ouchi K. et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009; 23: 367-372
• 47 Vigna L, Morelli F, Agnelli GM. et al. Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity: Could circulating pro-BDNF and BDNF be potential biomarkers?. Evid Based Complement Alternat Med 2019; 2019: 7861297
• 48 Saitsu Y, Nishide A, Kikushima K. et al. Improvement of cognitive functions by oral intake of Hericium erinaceus . Biomed Res 2019; 40: 125-131
• 49 Li IC, Chang HH, Lin CH. et al. Prevention of early Alzheimer’s disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Front Aging Neurosci 2020; 12: 155
• 50 Bizjak MC, Praznikar ZJ, Kenig S. et al. Effect of erinacine A-enriched Hericium erinaceus supplementation on cognition: A randomized, double-blind, placebo-controlled pilot study. J Funct Foods 2024; 115: 106120
• 51 Zhao T, Su Z, Li Y. et al. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther 2020; 5: 201
• 52 Nagano M, Shimizu K, Kondo R. et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res 2010; 31: 231-237
• 53 Inanaga K. Case report: Recovery from schizophrenia using Amyloban^®3399, compounds extracted from Hericium erinaceum . Int J Emerg Mental Health Hum Resilience 2015; 17: 203-205
• 54 Inanaga K, Matsuki T, Hoaki Y. et al. Improvement of refractory schizophrenia on using Amyloban^®3399 extracted from Hericium erinaceum . Personal Med Univ 2014; 3: 49-53
• 55 Inanaga K. Recovery from schizophrenia with bioactive substances in Hericium erinaceum . Int J School Cog Psychol 2015; S1: 1-3
• 56 Okamura H, Anno N, Tsuda A. et al. The effects of Hericium erinaceus (Amyloban^® 3399) on sleep quality and subjective well-being among female undergraduate students: A pilot study. Personal Med Univ 2015; 4: 76-78
• 57 Docherty S, Doughty FL, Smith EF. The acute and chronic effects of Lion’s Mane mushroom supplementation on cognitive function, stress and mood in young adults: A double-blind, parallel groups, pilot study. Nutrients 2023; 15: 4842
• 58 Li IC, Chen YL, Lee LY. et al. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats. Food Chem Toxicol 2014; 70: 61-67
• 59 Lakshmanan H, Raman J, David P. et al. Haematological, biochemical and histopathological aspects of Hericium erinaceus ingestion in a rodent model: A sub-chronic toxicological assessment. J Ethnopharmacol 2016; 194: 1051-1059
• 60 Lee LY, Li IC, Chen WP. et al. Thirteen-week oral toxicity evaluation of erinacine A enriched Lion’s Mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), mycelia in Sprague-Dawley rats. Int J Med Mushrooms 2019; 21: 401-411
• 61 Maes MF, van Baar HM, van Ginkel CJ. Occupational allergic contact dermatitis from the mushroom White Pom Pom (Hericium erinaceum). Contact Dermatitis 1999; 40: 289-290
• 62 Nakatsugawa M, Takahashi H, Takezawa C. et al. Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins. Intern Med 2003; 42: 1219-1222
• 63 Li IC, Chen YL, Chen WP. et al. Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium. Toxicol Rep 2014; 1: 1195-1201
• 64 Chen SN, Chang CS, Yang MF. et al. Subchronic toxicity and genotoxicity studies of Hericium erinaceus β-glucan extract preparation. Curr Res Toxicol 2022; 3: 100068